Sca-1+ Cell-Based Gene Therapy with a Modified Fibroblast Growth Factor 2 (FGF2) Increased Endosteal/Trabecular Bone Formation in Mice

被引：0
|
作者：
Hall, Susan L. [1 ,2 ]
Lau, K. -H. William [1 ,2 ]
Chen, Shin-Tai [1 ,2 ]
Sheng, Matilda H. -C. [1 ,2 ]
Srivastava, Apurva K. [1 ,2 ]
Klamut, Henry J. [1 ,2 ]
Wergedal, Jon E. [1 ,2 ]
Gridley, Daila S. [3 ]
Mohan, Subburaman [1 ,2 ]
Baylink, David J. [2 ]
机构：
[1] Loma Linda Univ, Loma Linda VAMC, MDC, Loma Linda, CA 92350 USA
[2] Loma Linda Univ, Dept Med, Loma Linda, CA 92350 USA
[3] Loma Linda Univ, Dept Rad Med, Loma Linda, CA 92350 USA
来源：
MOLECULAR THERAPY | 2006年 / 13卷
关键词：
D O I：
10.1016/j.ymthe.2006.08.517
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
449
引用
收藏
页码：S173 / S173
页数：1
相关论文
共 50 条
  • [21] Basic fibroblast growth factor (Fgf2) is necessary for cell proliferation and neurogenesis in the developing cerebral cortex
    Raballo, R
    Rhee, J
    Lyn-Cook, R
    Leckman, JF
    Schwartz, ML
    Vaccarino, FM
    JOURNAL OF NEUROSCIENCE, 2000, 20 (13): : 5012 - 5023
  • [22] Effect of basic fibroblast growth factor (FGF2) gene polymorphisms on SSRIs treatment response and side effects
    Kato, Masaki
    Okugawa, Gaku
    Wakeno, Masataka
    Takekita, Yoshiteru
    Nonen, Shinpei
    Tetsuo, Shinji
    Nishida, Keiichiro
    Azuma, Junichi
    Kinoshita, Toshihiko
    Serretti, Alessandro
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2009, 19 (10) : 718 - 725
  • [23] Basic fibroblast growth factor (FGF2) gene polymorphisms could contribute to SSRIs treatment response and tolerability
    Kato, M.
    Okugawa, G.
    Wakeno, M.
    Takekita, Y.
    Nounen, S.
    Tetsuo, S.
    Azuma, J.
    Serretti, A.
    Kinoshita, T.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2009, 19 : S405 - S406
  • [24] HoxA10 Protein Regulates Transcription of Gene Encoding Fibroblast Growth Factor 2 (FGF2) in Myeloid Cells
    Shah, Chirag A.
    Bei, Ling
    Wang, Hao
    Platanias, Leonidas C.
    Eklund, Elizabeth A.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2012, 287 (22) : 18230 - 18248
  • [25] Fibroblast growth factor-2 (FGF2) and FGF-receptor (FGFR-1) immunoreactivity in embryonic spinal autonomic neurons
    Stapf, C
    Luck, G
    Shakibaei, M
    Blottner, D
    CELL AND TISSUE RESEARCH, 1997, 287 (03) : 471 - 480
  • [26] Association between genetic polymorphisms in fibroblast growth factor (FGF)1 and FGF2 and risk of endometriosis and adenomyosis in Chinese women
    Kang, Shan
    Li, Shi-Zhen
    Wang, Na
    Zhou, Rong-Miao
    Wang, Tao
    Wang, Dong-Jie
    Li, Xiao-Fei
    Bui, Jack
    Li, Yan
    HUMAN REPRODUCTION, 2010, 25 (07) : 1806 - 1811
  • [27] The influence of fibroblast growth factor (FGF2) on cardiomyocytes differentiation of mesenchymal stem cells of bone marrow ex vivo
    Lobanok E.S.
    Kvacheva Z.B.
    Pinchuk S.V.
    Volk M.V.
    Mezhevikina L.M.
    Fesenko E.E.
    Volotovski I.D.
    Biophysics, 2014, 59 (2) : 293 - 300
  • [28] Electronegative LDL impairs vascular endothelial cell integrity in diabetes by disrupting fibroblast growth factor 2 (FGF2) autoregulation
    Lu, Jonathan
    Jiang, Wei
    Yang, Jun-Hai
    Chang, Po-Yuan
    Walterscheid, Jeffrey P.
    Chen, Hsin-Hung
    Marcelli, Marco
    Tang, Daming
    Lee, Yuan-Teh
    Liao, Warren S. L.
    Yang, Chao-Yuh
    Chen, Chu-Huang
    DIABETES, 2008, 57 (01) : 158 - 166
  • [29] Disruption of the fibroblast growth factor-2 gene in mice results in decreased bone mass and bone formation.
    Montero, A
    Okada, Y
    Tomita, M
    Ito, M
    Tsurukami, H
    Nakamura, T
    Doetchmann, T
    Coffin, JD
    Hurley, MM
    JOURNAL OF BONE AND MINERAL RESEARCH, 1999, 14 : S161 - S161
  • [30] Stem cell antigen-1+ cell-based bone morphogenetic protein-4 gene transfer strategy in mice failed to promote endosteal bone formation
    Hall, Susan L.
    Chen, Shin-Tai
    Gysin, Reinhard
    Gridley, Daila S.
    Mohan, Subburaman
    Lau, K-H William
    JOURNAL OF GENE MEDICINE, 2009, 11 (10): : 877 - 888
12345